Literature DB >> 10553737

Depressive symptoms in schizophrenia.

S Zisook1, L A McAdams, J Kuck, M J Harris, A Bailey, T L Patterson, L L Judd, D V Jeste.   

Abstract

OBJECTIVE: The authors assessed the presence and severity of depressive symptoms, as well as their associations with other clinical measures, in a group of mid- to late-life patients with schizophrenia who were not in a major depressive episode or diagnosed with schizoaffective disorder.
METHOD: Sixty outpatients with schizophrenia between the ages of 45 and 79 years and 60 normal comparison subjects without major neuropsychiatric disorders, proportionally matched for age and gender, were studied. Depressive symptoms were rated primarily with the Hamilton Depression Rating Scale. Standardized instruments were also used to measure global psychopathology, positive and negative symptoms, abnormalities of movement, and global cognitive status.
RESULTS: Depressive symptoms were more frequent and more severe in schizophrenic patients than in normal comparison subjects; 20% of the women with schizophrenia had a Hamilton depression scale score of 17 or more. Severity of depressive symptoms correlated with that of positive symptoms but not with age, gender, negative symptoms, extrapyramidal symptoms, or neuroleptic dose.
CONCLUSIONS: Depressive symptoms are common in older patients with schizophrenia. They may be an independent, core component of the disorder or, alternatively, may be a by-product of severe psychotic symptoms.

Entities:  

Mesh:

Year:  1999        PMID: 10553737     DOI: 10.1176/ajp.156.11.1736

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  34 in total

Review 1.  Psychological pathways to depression in schizophrenia: studies in acute psychosis, post psychotic depression and auditory hallucinations.

Authors:  Max Birchwood; Zaffer Iqbal; Rachel Upthegrove
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2005-06       Impact factor: 5.270

Review 2.  Pharmacological and clinical profile of recently approved second-generation antipsychotics: implications for treatment of schizophrenia in older patients.

Authors:  Jeffrey Rado; Philip G Janicak
Journal:  Drugs Aging       Date:  2012-10       Impact factor: 3.923

3.  Negative symptoms and their association with depressive symptoms in the long-term course of schizophrenia.

Authors:  Wolfram An der Heiden; Anne Leber; Heinz Häfner
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-04-23       Impact factor: 5.270

4.  What are residual symptoms in schizophrenia spectrum disorder? Clinical description and 1-year persistence within a naturalistic trial.

Authors:  Rebecca Schennach; Michael Riedel; Michael Obermeier; Ilja Spellmann; Richard Musil; Markus Jäger; Max Schmauss; Gerd Laux; Herbert Pfeiffer; Dieter Naber; Lutz G Schmidt; Wolfgang Gaebel; Joachim Klosterkötter; Isabella Heuser; Wolfgang Maier; Matthias R Lemke; Eckart Rüther; Stefan Klingberg; Markus Gastpar; Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-09-27       Impact factor: 5.270

5.  Psychiatric symptoms and mental health court engagement.

Authors:  Kelli E Canada; Greg Markway; David Albright
Journal:  Psychol Crime Law       Date:  2016-04-13

6.  Reducing emergency medical service use in patients with chronic psychotic disorders: results from the FAST intervention study.

Authors:  Brent T Mausbach; Veronica Cardenas; Christine L McKibbin; Dilip V Jeste; Thomas L Patterson
Journal:  Behav Res Ther       Date:  2007-10-07

7.  Functioning in middle aged and older patients with schizophrenia and depressive symptoms: relationship to psychopathology.

Authors:  John Kasckow; Thomas Patterson; Ian Fellows; Shahrokh Golshan; Ellen Solorzano; Somaia Mohamed; Sidney Zisook
Journal:  Am J Geriatr Psychiatry       Date:  2008-08       Impact factor: 4.105

Review 8.  Co-occurring depressive symptoms in the older patient with schizophrenia.

Authors:  John W Kasckow; Sidney Zisook
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

Review 9.  Aripiprazole for late-life schizophrenia.

Authors:  Jeffrey Rado; Philip G Janicak
Journal:  Clin Interv Aging       Date:  2010-09-07       Impact factor: 4.458

10.  Treatment of subsyndromal depressive symptoms in middle-aged and older adults with schizophrenia: effect on functioning.

Authors:  John Kasckow; Nicole Lanouette; Thomas Patterson; Ian Fellows; Shahrokh Golshan; Ellen Solorzano; Sidney Zisook
Journal:  Int J Geriatr Psychiatry       Date:  2010-02       Impact factor: 3.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.